Clinical trials
Genital Diseases, Male trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 6 |
| Terminated | 4 |
| Unknown status | 3 |
| Withdrawn | 1 |
| Approved for marketing | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Miami | 3 |
| VA Office of Research and Development | 2 |
| Advanced Accelerator Applications | 1 |
| Alessandro D'Agnolo | 1 |
| Aragon Pharmaceuticals, Inc. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Celcuity Inc | 1 |
| Duke University | 1 |
| ESSA Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Diseases, Male | 25 |
| Prostatic Diseases | 12 |
| Prostatic Neoplasms | 12 |
| Genital Neoplasms, Male | 11 |
| Urogenital Neoplasms | 10 |
| Male Urogenital Diseases | 9 |
| Neoplasms | 6 |
| Neoplasms by Site | 6 |
| Endocrine System Diseases | 4 |
| Gonadal Disorders | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.